Related Experiment Video
Updated: Aug 17, 2026
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Molecular methods of hepatitis C genotyping
1University of North Carolina, Campus Box 7525, Chapel Hill, NC 27599-7525, USA. kweck@unc.edu
Insights
Hepatitis C virus (HCV) genotyping is crucial for monitoring chronic infections and predicting outcomes. This review explores current and future HCV genotyping methods to improve patient management and treatment strategies.
Area of Science:
- Virology
- Hepatology
- Infectious Diseases
Background:
- Hepatitis C virus (HCV) causes chronic infection, leading to severe liver disease like cirrhosis and cancer.
- HCV infection is a major cause of liver transplantation in the USA.
- Genotyping HCV is vital for monitoring chronic infections and guiding therapy.
Purpose of the Study:
- To review current and emerging methods for Hepatitis C virus genotyping.
- To discuss limitations of existing commercial genotyping assays.
- To highlight future directions for HCV genotyping assay development.
Main Methods:
- Review of existing literature on Hepatitis C virus genotyping techniques.
- Analysis of limitations in current commercially available assays.
- Exploration of novel and developing genotyping methodologies.
Main Results:
- Hepatitis C virus genotyping is essential for prognostic assessment and treatment duration.
- Current commercial methods have limitations that impact clinical utility.
- Advancements in genotyping are needed to improve accuracy and accessibility.
Conclusions:
- Hepatitis C virus genotyping plays a critical role in managing chronic HCV infections.
- Further development of HCV genotyping assays is necessary for better patient outcomes.
- Future research should focus on overcoming limitations of current methods and exploring innovative approaches.
Abstract:
Hepatitis C virus is an RNA virus that is associated with chronic infection in the majority of people infected. Chronic infection with hepatitis C virus is the cause of significant morbidity and mortality worldwide and is associated with a large spectrum of liver disease including cirrhosis and hepatocellular carcinoma. End-stage liver disease due to chronic hepatitis C virus infection is currently the leading indication for liver transplantation in the USA. Hepatitis C virus genotyping of viral isolates circulating in the blood during chronic infection has become an important part of hepatitis C virus monitoring in chronically infected patients, and is useful as a prognostic indicator and to direct duration of therapy. This review will summarize information on hepatitis C genotyping, describe the limitations of current commercially available methods, give information on more recently developed methods, and provide a look to the future in terms of where advances in hepatitis C virus genotyping assays need to be made.
Related Concept Videos
01:25Hepatitis
01:29Modern Molecular Taxonomy